Similar articles

• Methylation of the CTLA-4 promoter and Treg cell dysfunction in rheumatoid arthritis: comment on the article by Cribbs et al.

  Liebling MR. Liebling MR. Arthritis Rheumatol. 2015 May;67(5):1406. doi: 10.1002/art.39040. Arthritis Rheumatol. 2015. PMID: 25605228 No abstract available.
• Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway.

  Cribbs AP, Kennedy A, Penn H, Read JE, Amjadi P, Green P, Syed K, Manka SW, Brennan FM, Gregory B, Williams RO. Cribbs AP, et al. Arthritis Rheumatol. 2014 Sep;66(9):2344-54. doi: 10.1002/art.38715. Arthritis Rheumatol. 2014. PMID: 24891289
• CD14(+) regulatory dendritic cells in patients with hepatocellular carcinoma and cirrhosis.

  Tanoue S, Kaplan DE. Tanoue S, et al. Hepatology. 2016 Apr;63(4):1391-2. doi: 10.1002/hep.28419. Epub 2016 Feb 19. Hepatology. 2016. PMID: 26703333 Free PMC article. No abstract available.
• Interaction of indoleamine-2,3-dioxyagnase and CD4+CD25+ regulatory T cells in tumor immune escape.

  Wang H, Pan K, Xia JC. Wang H, et al. Ai Zheng. 2009 Feb;28(2):184-7. Epub 2009 Feb 12. Ai Zheng. 2009. PMID: 19550135 Review.
• [Mechanism of bone destruction and the contribution of T lymphocytes].

  Komatsu N. Komatsu N. Nihon Rinsho. 2016 Jun;74(6):907-12. Nihon Rinsho. 2016. PMID: 27311177 Review. Japanese.